Solace Lifesciences, Inc.
PrivateLast Round
Seed
Dec 14, 2017
Total Funding Raised
$1.55M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Solace Lifesciences, Inc. operates in Healthcare & Life Sciences and is based in Wilmington, Delaware. Its latest recorded funding round was a Seed round in December 2017.
Solace Lifesciences, Inc. is a health technology company that develops and markets NuCalm, a patented, drug-free neuroscience technology platform designed to reduce stress and improve sleep quality.
Sector
Healthcare & Life Sciences
Verticals
Mental Health, Medical Devices, Sports & Fitness, Subscription Commerce
Business Model
B2C
Customer Profile
Subscription SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Solace Lifesciences, Inc. Comparables
Compare Solace Lifesciences, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BrainTap | 87% | |
| Sensate | 77% | |
| InteraXon Inc. | 77% |
For institutional investors. Book with your work email.
Solace Lifesciences, Inc. Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 25, 2026
Grew 50% QoQ from 8 to 12 employees.
- Dec 14, 2017
$1.55M round led by Third Seven Capital.
For institutional investors. Book with your work email.
Solace Lifesciences, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Solace Lifesciences, Inc.'s valuation, stock price, and market status.
Is Solace Lifesciences, Inc. a public or private company?
Solace Lifesciences, Inc. is a private company.
What is the current stock price of Solace Lifesciences, Inc.?
Solace Lifesciences, Inc. is a private company, so its shares have no public market price. Caplight tracks Solace Lifesciences, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Solace Lifesciences, Inc. worth (valuation)?
Valuation information for Solace Lifesciences, Inc. is not publicly available.
Can I buy Solace Lifesciences, Inc. stock?
Solace Lifesciences, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Solace Lifesciences, Inc.'s last funding round?
Solace Lifesciences, Inc.'s most recent funding round was Seed on December 14, 2017.
Who are the main investors in Solace Lifesciences, Inc.?
Investor information for Solace Lifesciences, Inc. is not publicly disclosed.
Will Solace Lifesciences, Inc. IPO soon?
No public IPO plans have been announced for Solace Lifesciences, Inc..
How can I track Solace Lifesciences, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Solace Lifesciences, Inc.'s shares on secondary markets.